Company Angiospectru Med Srl with Fiscal Code 16894101
recorded a turnover of 2024 of
5.744.813,
with a net profit of
1.106.061
and having an average number of employees of
7.
The company operates in the field of Comerţ cu ridicata al produselor farmaceutice și medicale having the NACE code 4646.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Angiospectru Med Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
1.701.446
2.252.546
2.120.204
2.549.189
2.549.045
2.420.331
3.194.660
3.290.187
4.036.833
5.744.813
Total Income - EUR
1.726.551
2.338.618
2.138.802
2.574.429
2.595.445
2.432.387
3.205.437
3.318.571
4.062.235
6.045.113
Total Expenses - EUR
1.320.953
1.717.856
1.705.705
2.100.120
2.188.430
2.054.621
2.619.539
2.765.923
3.258.330
4.770.443
Gross Profit/Loss - EUR
405.598
620.762
433.097
474.309
407.015
377.766
585.898
552.648
803.906
1.274.670
Net Profit/Loss - EUR
337.642
515.245
352.089
402.645
346.556
321.200
490.666
442.177
706.309
1.106.061
Employees
2
5
5
6
7
9
9
9
7
7
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 43.1%, from 4.036.833 euro in the year 2023, to 5.744.813 euro in 2024.
The Net Profit increased by 403.699 euro, from 706.309 euro in 2023, to 1.106.061 in the last year.
Check the financial reports for the company - Angiospectru Med Srl
Financial Rating - ANGIOSPECTRU MED SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Angiospectru Med Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Angiospectru Med Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Angiospectru Med Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Angiospectru Med Srl - CUI 16894101
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
49.474
58.213
362.193
338.601
364.987
333.601
302.849
294.857
304.262
124.434
Current Assets
1.926.821
1.669.552
1.476.633
1.515.559
1.673.696
1.505.188
1.729.102
2.434.907
2.779.307
3.089.080
Inventories
357.018
481.271
505.235
337.646
360.807
316.432
347.047
394.324
547.308
752.818
Receivables
760.016
577.403
538.393
816.603
679.751
659.493
708.719
1.259.807
1.095.920
1.038.112
Cash
809.787
610.878
433.005
361.310
633.138
529.263
673.336
780.776
1.136.078
1.298.150
Shareholders Funds
662.713
515.434
352.286
402.839
346.746
661.373
804.926
442.360
923.511
1.134.850
Social Capital
169
167
164
161
158
155
152
152
152
151
Debts
1.028.219
1.212.936
1.389.116
1.380.399
1.602.992
1.083.218
1.117.651
1.969.546
1.886.720
1.891.761
Income in Advance
285.363
50.228
94.478
67.267
86.179
92.438
109.750
315.986
272.211
194.749
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"4646 - 4646"
CAEN Financial Year
4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
3.089.080 euro in 2024 which includes Inventories of
752.818 euro, Receivables of
1.038.112 euro and cash availability of
1.298.150 euro.
The company's Equity was valued at
1.134.850 euro, while total Liabilities amounted to
1.891.761 euro.
Equity increased by 216.500 euro, from 923.511 euro in 2023, to 1.134.850 in 2024.
The Debt Ratio was 58.7% in the year 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Angiospectru Med Srl